Effects of Systemic Drugs on Intraocular Pressure

Last updated: April 7, 2022
Sponsor: Benha University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Vascular Diseases

Stress

Ocular Hypertension

Treatment

N/A

Clinical Study ID

NCT05328921
Rc 9-22
  • Ages 35-70
  • All Genders

Study Summary

To assess intraocular pressure changes among glaucoma patients on systemic antihypertensive and antihistaminic drugs.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with narrow angle glaucoma on systemic antihypertensive and/or antihistaminicdrugs.

Exclusion

Exclusion Criteria:

  • open angle glaucoma patients confirmed by gonioscopy examination.
  • Cases with dense corneal opacity or iris trauma that may affects gonioscopyexamination.
  • cases with secondary glaucoma.

Study Design

Total Participants: 200
Study Start date:
April 07, 2022
Estimated Completion Date:
September 30, 2022

Study Description

Changes in intraocular pressure in glaucomatous patients with narrow angle may elicit attacks of angle closure glaucoma.

In this study we aim to assess changes in intraocular pressure (IOP) among glaucomatous patients on systemic antihypertensive and antihistaminic drugs.

Connect with a study center

  • Ahmed Abdelshafy

    Banhā, QA 13511
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.